as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
6.11%
Downside
1.31%
Upside
52 Week's Low
52 Week's High
28.33%
Downside
47.39%
Upside
Check Jade Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$280.1M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Jade Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $280.1M | NA | NA | 0.00% | |
| BUY | $40.5B | 482.44% | -16.34 | -264.83% | |
| BUY | $58.2B | 238.64% | 1420.94 | 1.36% | |
| BUY | $105.6B | 85.89% | 29.33 | 31.35% | |
| BUY | $68.0B | 13.75% | 15.51 | 32.13% |
Search interest for Jade Biosciences Inc Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 year, JBIO stock has moved up by 229.0%
Best in 1 Year
![]()
In the last 1 year, JBIO has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 897.2% return, outperforming this stock by 948.1%
| Organisation | Jade Biosciences Inc |
| Headquarters | Building 23, Waltham, MA, United States, 02453 |
| CEO | Mr. Tom Frohlich |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Andrew James King D.V.M., Ph.D. | Chief Scientific Officer & Head of R&D |
Ms. Elizabeth Balta | General Counsel & Corporate Secretary |
Ms. Lori Stewart | Senior Vice President of People |
Mr. Jonathan Quick | Senior Vice President of Finance |
Ms. Valerie Fauvelle | Senior Vice President of Regulatory & Quality |
Ms. Sandy Lewis | Senior Vice President, Biometrics & Clinical Strategy |
Mr. Tom Frohlich | CEO & Director |
Mr. Bradford D. Dahms Ph.D. | Chief Financial Officer |
Dr. Jason Wright Ph.D. | Senior Vice President of Chemistry, Manufacturing & Controls |
Ms. Amy Sullivan | Senior Vice President of Development Operations |
Jade Biosciences Inc share price today is $9.16 as on at the close of the market. Jade Biosciences Inc share today touched a day high of $9.28 and a low of $8.6.
Jade Biosciences Inc share touched a 52 week high of $13.5 on and a 52 week low of $6.57 on . Jade Biosciences Inc stock price today i.e. is closed at $9.16,which is 32.15% down from its 52 week high and 39.53% up from its 52 week low.
Jade Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Jade Biosciences Inc (JBIO) shares with as little as ₹88.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.60 in Jade Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Jade Biosciences Inc share’s latest price of $9.16 as on November 8, 2025 at 2:29 am IST, you will get 1.0917 shares of Jade Biosciences Inc. Learn more about
fractional shares .